XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at Dec. 31, 2021 $ 30 $ 60   $ 85,414   $ 343,459 $ 1,517   $ 430,480
Increase (decrease) in shareholders' equity                  
Net Income Attributable to the Company           1,420     1,420
Stock Repurchase       (1,147)         (1,147)
Vested Restricted Stock and Performance Shares       (845)         (845)
Exercise of Stock Options and Stock Issuance to Directors       237         237
Stock Issuance, Net of Equity Issuance Costs   1   8,478         8,479
Stock-Based Compensation Expense       1,244         1,244
Preferred Stock Dividends Declared for the Period           (2,391)     (2,391)
Common Stock Dividends Declared for the Period           (13,594)     (13,594)
Other Comprehensive Income             10,623   10,623
Balance at Jun. 30, 2022 30 61 $ (7,034) 86,347 $ 4,022 332,916 12,140 $ (3,012) 431,494
Balance at Dec. 31, 2021 30 60   85,414   343,459 1,517   430,480
Balance at Dec. 31, 2022 30 229   172,471   316,279 15,761   504,770
Balance at Mar. 31, 2022 30 60   81,092   339,828 9,529   430,539
Increase (decrease) in shareholders' equity                  
Net Income Attributable to the Company           1,218     1,218
Stock Repurchase       (1,147)         (1,147)
Exercise of Stock Options and Stock Issuance to Directors       88         88
Stock Issuance, Net of Equity Issuance Costs   1   5,689         5,690
Stock-Based Compensation Expense       625         625
Preferred Stock Dividends Declared for the Period           (1,196)     (1,196)
Common Stock Dividends Declared for the Period           (6,934)     (6,934)
Other Comprehensive Income             2,611   2,611
Balance at Jun. 30, 2022 30 61 $ (7,034) 86,347 $ 4,022 332,916 12,140 $ (3,012) 431,494
Balance at Dec. 31, 2022 30 229   172,471   316,279 15,761   504,770
Balance at Mar. 31, 2023 30 227   167,436   300,066 10,870   478,629
Balance at Dec. 31, 2022 30 229   172,471   316,279 15,761   504,770
Increase (decrease) in shareholders' equity                  
Net Income Attributable to the Company           (4,193)     (4,193)
Stock Repurchase   (3)   (5,082)         (5,085)
Vested Restricted Stock and Performance Shares   1   (1,029)         (1,028)
Exercise of Stock Options and Stock Issuance to Directors       241         241
Payment of Equity Issuance Costs       122         122
Stock-Based Compensation Expense       1,624         1,624
Preferred Stock Dividends Declared for the Period           (2,390)     (2,390)
Common Stock Dividends Declared for the Period           (17,738)     (17,738)
Other Comprehensive Income             2,488   2,488
Balance at Jun. 30, 2023 30 227   168,103   291,958 18,249   478,567
Balance at Mar. 31, 2023 30 227   167,436   300,066 10,870   478,629
Increase (decrease) in shareholders' equity                  
Net Income Attributable to the Company           1,800     1,800
Stock Repurchase       (76)         (76)
Payment of Equity Issuance Costs       51         51
Stock-Based Compensation Expense       794         794
Preferred Stock Dividends Declared for the Period           (1,195)     (1,195)
Common Stock Dividends Declared for the Period           (8,713)     (8,713)
Other Comprehensive Income             7,379   7,379
Balance at Jun. 30, 2023 $ 30 $ 227   $ 168,103   $ 291,958 $ 18,249   $ 478,567